Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 20, 2024
Functional genomics and small molecules in mitochondrial neurodevelopmental disordersDaniel G Calame, Lisa T Emrick
Neurology. Genetics|February 8, 2021
<i>EIF2AK2</i>-related Neurodevelopmental Disorder With Leukoencephalopathy, Developmental Delay, and Episodic Neurologic Regression Mimics Pelizaeus-Merzbacher DiseaseDaniel G Calame, Meagan Hainlen, Danielle Takacs, et al.
Physical Medicine and Rehabilitation Clinics of North America|November 26, 2019
The Expanding Role of Genetics in Cerebral PalsyLisa T Emrick, Shannon M DiCarlo
Annual Review of Medicine|January 14, 2011
Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cellsRick A Wetsel, Dachun Wang, Daniel G Calame
Epilepsy & Behavior Reports|February 8, 2021
A <i>de novo</i> heterozygous rare variant in <i>SV2A</i> causes epilepsy and levetiracetam-induced drug-resistant status epilepticusDaniel G Calame, Isabella Herman, James J Riviello
Molecular Genetics and Metabolism|July 24, 2012
Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disordersAyman W El-Hattab, Lisa T Emrick, William J Craigen, et al.
Immunobiology|August 2, 2016
Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infectionDaniel G Calame, Stacey L Mueller-Ortiz, Rick A Wetsel
Neurology. Genetics|April 30, 2024
<i>ATP1A3</i> Disease Spectrum Includes Paroxysmal Weakness and Encephalopathy Not Triggered by FeverChetan Immanneni, Daniel Calame, Song Jiao, et al.
The International Journal of Biochemistry & Cell Biology|January 14, 2014
Mitochondria: role of citrulline and arginine supplementation in MELAS syndromeAyman W El-Hattab, Lisa T Emrick, Sirisak Chanprasert, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|February 12, 2021
A novel ATP1A2 variant associated with severe stepwise regression, hemiplegia, epilepsy and movement disorders in two unrelated patientsDaniel G Calame, Kimberly Houck, Timothy Lotze, et al.
Pageof 9